Diagnosis, remission status by conditioning regimen
| . | Flu/Mel (n = 46) . | TBI/VP16 (n = 28) . | Bu/Cy (n = 11) . |
|---|---|---|---|
| ALL | 4 (2CR, 2A) | 14 (12CR, 2A) | |
| AML | 19 (15CR, 4A) | 12 (8CR, 4A) | 2 (2A) |
| CML | 5 (4CP, 1AP) | ||
| Lymphoma/CLL | 14 (14A) | 2 (1CR, 1A) | |
| MDS | 2 (2A) | 4 (3CR, 1A) | |
| Multiple myeloma | 3 (3A) | ||
| Myeloproliferative disorder | 4 (4CP) |
| . | Flu/Mel (n = 46) . | TBI/VP16 (n = 28) . | Bu/Cy (n = 11) . |
|---|---|---|---|
| ALL | 4 (2CR, 2A) | 14 (12CR, 2A) | |
| AML | 19 (15CR, 4A) | 12 (8CR, 4A) | 2 (2A) |
| CML | 5 (4CP, 1AP) | ||
| Lymphoma/CLL | 14 (14A) | 2 (1CR, 1A) | |
| MDS | 2 (2A) | 4 (3CR, 1A) | |
| Multiple myeloma | 3 (3A) | ||
| Myeloproliferative disorder | 4 (4CP) |
AML indicates acute myelogenous leukemia; ALL, acute lymphoblastic leukemia; CML, chronic myelogenous leukemia; and CLL, chronic lymphocytic leukemia; MDS, myelodysplastic syndrome; A, active; AP, accelerated phase; CR, complete remission; and CP, chronic phase.